tetanus peptide melanoma vaccine
Term · Oncology and biomedicine · MLC-T-ONC-017085
A vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth.
| Identifier | MLC-T-ONC-017085 |
|---|---|
| Field | Oncology and biomedicine |
| Abbreviation | Tet p |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017085",
"term": "tetanus peptide melanoma vaccine",
"field": "Oncology and biomedicine",
"definition": "A vaccine consisting of peptides derived from melanoma-associated antigens and a modified T-cell epitope derived from tetanus toxoid. Vaccination with this agent may stimulate a host cytotoxic and helper T-cell response against tumor cells expressing melanoma-associated antigens, resulting in decreased tumor growth.",
"abbreviation": "Tet p",
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tetanus-peptide-melanoma-vaccine/"
}
Record 16,193 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.